BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32282780)

  • 1. D-Dimer Could Be a Surrogate Postoperative Prognostic Marker of Resectable Pancreatic Cancer.
    Watanabe A; Harimoto N; Araki K; Kubo N; Igarashi T; Tsukagoshi M; Ishii N; Yamanaka T; Hagiwara K; Hoshino K; Muranushi R; Shirabe K
    Pancreas; 2020 Apr; 49(4):e36-e38. PubMed ID: 32282780
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma.
    Cao J; Fu Z; Gao L; Wang X; Cheng S; Wang X; Ren H
    World J Surg Oncol; 2017 Feb; 15(1):48. PubMed ID: 28219450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
    Court CM; Ankeny JS; Sho S; Winograd P; Hou S; Song M; Wainberg ZA; Girgis MD; Graeber TG; Agopian VG; Tseng HR; Tomlinson JS
    Ann Surg Oncol; 2018 Apr; 25(4):1000-1008. PubMed ID: 29442211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels: A Retrospective Multicenter Cohort Study.
    Aziz MH; Sideras K; Aziz NA; Mauff K; Haen R; Roos D; Saida L; Suker M; van der Harst E; Mieog JS; Bonsing BA; Klaver Y; Koerkamp BG; van Eijck CH
    Ann Surg; 2019 Jul; 270(1):139-146. PubMed ID: 29334554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.
    Watanabe A; Araki K; Harimoto N; Kubo N; Igarashi T; Ishii N; Yamanaka T; Hagiwara K; Kuwano H; Shirabe K
    Int J Clin Oncol; 2018 Aug; 23(4):689-697. PubMed ID: 29574651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma.
    Saukkonen K; Hagström J; Mustonen H; Lehtinen L; Carpen O; Andersson LC; Seppänen H; Haglund C
    Tumour Biol; 2018 Mar; 40(3):1010428318761494. PubMed ID: 29542402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concentration of D-dimers in portal blood positively correlates with overall survival in patients with non-resectable pancreatic cancer.
    Durczynski A; Skulimowski A; Hogendorf P; Szymanski D; Kumor A; Marski K; Juliebø SØ; Poznanska G; Strzelczyk J
    World J Surg Oncol; 2017 Dec; 15(1):223. PubMed ID: 29246148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of CA19-9 following resection for pancreatic ductal adenocarcinoma is not tantamount to being cured?
    Chen T; Zhang MG; Yu XJ; Liu L
    Asian Pac J Cancer Prev; 2015; 16(2):661-6. PubMed ID: 25684504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.
    Park JB; Kim YH; Kim J; Chang HM; Kim TW; Kim SC; Kim PN; Han DJ
    J Vasc Interv Radiol; 2012 May; 23(5):635-41. PubMed ID: 22525021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
    Kim NH; Kim HJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor size significantly correlates with postoperative liver metastases and COX-2 expression in patients with resectable pancreatic cancer.
    Matsumoto G; Muta M; Tsuruta K; Horiguchi S; Karasawa K; Okamoto A
    Pancreatology; 2007; 7(2-3):167-73. PubMed ID: 17592230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism.
    Sun W; Ren H; Gao CT; Ma WD; Luo L; Liu Y; Jin P; Hao JH
    Am J Clin Oncol; 2015 Dec; 38(6):550-6. PubMed ID: 24401666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors.
    Cai HX; Li XQ; Wang SF
    World J Gastroenterol; 2018 Nov; 24(44):5046-5056. PubMed ID: 30510379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence and survival after surgery for pancreatic cancer with or without acute pancreatitis.
    Feng Q; Li C; Zhang S; Tan CL; Mai G; Liu XB; Chen YH
    World J Gastroenterol; 2019 Oct; 25(39):6006-6015. PubMed ID: 31660036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer.
    Rahbari NN; Schmidt T; Falk CS; Hinz U; Herber M; Bork U; Büchler MW; Weitz J; Koch M
    BMC Cancer; 2011 Jul; 11():286. PubMed ID: 21729304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative cell-free mutant KRAS dynamics in patients with pancreatic cancer.
    Hipp J; Hussung S; Timme-Bronsert S; Boerries M; Biesel E; Fichtner-Feigl S; Fritsch R; Wittel UA
    Br J Surg; 2021 Apr; 108(3):239-243. PubMed ID: 33793718
    [No Abstract]   [Full Text] [Related]  

  • 19. Preoperative Plasma Fibrinogen and D-dimer as Prognostic Biomarkers for Non-Muscle-Invasive Bladder Cancer.
    Li X; Shu K; Zhou J; Yu Q; Cui S; Liu J; Zhou R; Ding D
    Clin Genitourin Cancer; 2020 Feb; 18(1):11-19.e1. PubMed ID: 31787543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma.
    Arima K; Yamashita YI; Hashimoto D; Nakagawa S; Umezaki N; Yamao T; Tsukamoto M; Kitano Y; Yamamura K; Miyata T; Okabe H; Ishimoto T; Imai K; Chikamoto A; Baba H
    Am J Surg; 2018 Jul; 216(1):111-115. PubMed ID: 28859917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.